FSH test for perimenopause: what it can and cannot tell you

An FSH test measures follicle-stimulating hormone, the signal your pituitary gland sends to your ovaries. FSH does rise across perimenopause, but it rises unevenly and swings from month to month, so one result can look normal in a woman who is clearly in the transition, or high in one who is not. The test is useful in specific situations, mainly under 40, rather than as a yes-or-no answer for perimenopause.

What FSH is and why it rises

The FDA describes FSH as a pituitary hormone that rises temporarily each month to stimulate the ovaries to produce eggs, and that rises when the ovaries stop working at menopause. In the years before, the ovaries respond less readily, so the pituitary sends a stronger signal.

The best timeline comes from SWAN, which measured FSH every year in 1,215 women until their final period. Average FSH began rising about 6 years before the final period, accelerated about 2 years before it, and stabilized about 2 years after. The pattern was the same regardless of age at the final period, race or ethnicity, or smoking. Obesity blunted the rise and delayed its start, which is one reason the same FSH value can mean different things in different women.

For how FSH fits with estrogen and progesterone, see what happens to your hormones in perimenopause.

Typical FSH levels by stage

The most useful US reference comes from the National Health and Nutrition Examination Survey (NHANES), which tested a nationally representative sample of 576 women aged 35 to 60.

Stage	Average FSH (geometric mean)
Reproductive years	7.0 mIU/mL
Menopause transition	21.9 mIU/mL
Postmenopause	45.7 mIU/mL

The averages climb neatly. Individual results do not. The researchers found considerable overlap between the stages, and only age and reproductive stage were significantly linked to FSH.

How well FSH separates the stages

The NHANES team tested the cutoffs that best divided the stages:

Question	FSH cutoff	Sensitivity	Specificity
Reproductive years or transition?	13 mIU/mL	67.4%	88.1%
Transition or postmenopause?	45 mIU/mL	73.6%	70.6%

In plain terms, the 13 mIU/mL cutoff missed about a third of women who were in the transition. The 45 mIU/mL cutoff missed about a quarter of postmenopausal women and labeled about 3 in 10 women still in the transition as postmenopausal. The authors concluded that FSH by itself has limited value for telling the stages apart.

The Endocrine Society’s guideline reaches the same conclusion from a clinical angle: in a woman with a uterus, FSH and other hormone measurements do not further inform the diagnosis, do not indicate precisely when the final period will occur, and cannot distinguish late perimenopause from early postmenopause on their own.

Why one result misleads

• FSH fluctuates. The FDA notes that as you get older, FSH levels may rise and fall during your menstrual cycle. Our guide to why hormone tests are often normal explains the estrogen surges behind this.
• Timing within the cycle matters. FSH rises temporarily each month, so the day of the draw affects the number.
• Hormonal medications distort it. ACOG advises measuring FSH only in women who are not taking hormonal medications, including birth control pills. The FDA lists oral or patch contraceptives, hormone therapy and estrogen supplements as factors that affect home FSH results.
• Body weight changes the pattern. In SWAN, obesity attenuated the FSH rise.

When an FSH test is useful

Under 40. This is the main use. Irregular or absent periods before 40 raise the question of primary ovarian insufficiency. ACOG recommends FSH and estradiol along with tests for pregnancy, thyroid disease and high prolactin. If FSH is in the menopausal range, typically above 30 to 40 mIU/mL depending on the laboratory, the test is repeated in 1 month, and if it is still elevated the diagnosis can be made. The Endocrine Society notes that persistently raised FSH under 40 provides a tentative diagnosis. See primary ovarian insufficiency.

No periods to go by. After a hysterectomy that kept the ovaries, the cycle cannot be used. The Endocrine Society notes that raised FSH with estradiol below 20 pg/mL on several occasions supports, but does not confirm, menopause.

Unclear cases. When symptoms are atypical or start early, FSH can be one piece of a broader workup, interpreted alongside the history rather than on its own.

When it is not useful

• Confirming perimenopause in your 40s. Age, cycle pattern and symptoms do that better.
• Predicting your final period. The Endocrine Society states hormone measurements do not indicate precisely when it will occur.
• Deciding to stop contraception. The CDC states that no reliable laboratory tests can confirm loss of fertility and that FSH levels might not be accurate for this purpose. The FDA warns not to stop contraceptives based on home FSH results.

If you have already had a result

Your result	What it means	What it does not mean
Normal FSH	FSH was in the normal range that day	That you are not in perimenopause
High FSH	Your ovaries were responding less readily that day	That you are in menopause or can no longer get pregnant
High FSH under 40	A reason for a repeat test in about a month	A diagnosis on its own

Home FSH tests

Home urine FSH kits use the same principle. The FDA says they accurately detect FSH about 9 out of 10 times, that some are identical to tests used in doctors’ offices, and that they do not detect menopause or perimenopause. Our guide to at-home menopause tests covers the different kit types.

When to see a clinician

• You are under 40 and your periods have become irregular or stopped
• You were told your symptoms cannot be perimenopause because your FSH was normal; our guide to self-advocacy at the doctor can help with that conversation
• You have very heavy bleeding, bleeding between periods or any bleeding after 12 months without a period
• You want to talk through contraception or treatment options

The symptom check can help you prepare. To find a clinician, search for an ob-gyn near you.